Genotype modulators of clinical severity in McArdle disease

Neuroscience Letters

Volumn 422, Issue 3, 2007, Pages 217-222

  Rubio, Juan C ^a,b   Gómez Gallego, Félix ^c   Santiago, Catalina ^c   García Consuegra, Inés ^a,b   Pérez, Margarita ^c   Barriopedro, María I ^c   Andreu, Antoni L ^b,d   Martín, Miguel A ^a,b   Arenas, Joaquín ^a,b   Lucia, Alejandro ^c  

^a HOSPITAL UNIVERSITARIO 12 DE OCTUBRE   (Spain)

^b CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^c UNIVERSIDAD EUROPEA DE MADRID   (Spain)

^d HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

ACE; ACTN3; AMPD1; PPARGC1A; PYGM

Indexed keywords

GLYCOGEN PHOSPHORYLASE;

ADOLESCENT; ADULT; AGED; ALLELE; ARTICLE; CLINICAL FEATURE; CORRELATION COEFFICIENT; DISEASE SEVERITY; ENZYME DEFICIENCY; FEMALE; GENETIC ASSOCIATION; GENOTYPE; GENOTYPE PHENOTYPE CORRELATION; GLYCOGEN STORAGE DISEASE TYPE 5; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; PRIORITY JOURNAL; SCHOOL CHILD; SCORING SYSTEM; SEX DIFFERENCE;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ALLELES; CHILD; FEMALE; GENOTYPE; GLYCOGEN STORAGE DISEASE TYPE V; HUMANS; MALE; MIDDLE AGED; PEPTIDYL-DIPEPTIDASE A; SEX FACTORS;

EID: 34447509255     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neulet.2007.06.025     Document Type: Article

References (42)

1. Attie A.D., and Kendziorski C.M. PGC-1alpha at the crossroads of type 2 diabetes. Nat. Genet. 34 (2003) 244-245
2. Brooks G.A., Butterfield G.E., and Wolfe R.R. Increased dependence on blood glucose after acclimatization to 4300 m. J. Appl. Physiol. 70 (1991) 919-927
3. Bruno C., Cassandrini D., Martinuzzi A., Moggio M., Morandi L., Servidei S., Mongini T., Angelini C., Musumeci O., Comi G.P., Lamperti C., Filosto M., Zara F., and Minetti C. McArdle disease: the mutation spectrum of PYGM in a large Italian cohort. Hum. Mutat. 27 (2006) 718
4. Crow M.T., and Kushmerick M.J. Chemical energetics of slow- and fast-twitch muscles of the mouse. J. Gen. Physiol. 79 (1982) 147-166
5. Ek J., Andersen G., Urhammer S.A., Drivsholm T., Borch-Johnsen K., Hansen T., and Pedersen O. Mutation analysis of peroxisome proliferator-activated receptor-gamma coactivator-1 (PGC-1) and relationships of identified amino acid polymorphisms to type II diabetes mellitus. Diabetologia 44 (2001) 2220-2226
6. Finck B.N., and Kelly D.P. PGC-1 coactivators: inducible regulators of energy metabolism in health and disease. J. Clin. Invest. 116 (2006) 615-622
7. 2max. Med. Sci. Sports Exercise 35 (2003) 1998-2004
8. Gayagay G., Yu B., Hambly B., Hahn A., Celermajer D.S., and Trent R.J. Elite endurance athletes and the ACE I allele-the role of genes in athletic performance. Hum. Genet. 103 (1998) 48-50
9. Haller R.G., Wyrick P., Taivassalo T., and Vissing J. Aerobic conditioning: An effective therapy in McArdle's disease. Ann. Neurol. 59 (2006) 922-928
10. Hamroff G., Katz S.D., Mancini D., Bijou R., Patel R., Jondeau G., Olivari M.T., Thomas S., and Le Jemtel T.H. Addition of angiotensin II receptor blockade to maximal angiotensin-converting enzyme inhibition improves exercise capacity in patients with severe congestive heart failure. Circulation 99 (1999) 990-992
11. Heller S.L., Kaiser K.K., Planner G.J., and Brooke M.H. McArdle's disease with myoadenylate deficiency: observations in a combined enzyme deficiency. Neurology 37 (1987) 1039-1042
12. Henriksen E.J., and Jacob S. Effect of captopril on glucose transport activity in skeletal muscle of Obese Zucker rats. Metabolism 44 (1995) 267-272
13. Henriksen E.J., Jacob S., Kinnick T.R., Schmit M.B., and Dietze G.J. ACE inhibition and glucose transport in insulin resistant muscle: roles of bradykinin and nitric oxide. Am. J. Physiol. Regul. Integr. Comp. Physiol. 277 (1999) R332-R336
14. Jacob S., Henriksen E.J., Fogt D.L., and Dietze G.J. Effects of trandolapril and verapamil on glucose transport in insulin-resistant rat skeletal muscle. Metabolism 45 (1996) 535-541
15. Ling C., Poulsen P., Carlsson E., Almgren P., Wojtaszewski J., Beck-Nielsen H., Groop L., and Vaag A. Multiple environmental and genetic factors influence skeletal muscle PGC-1α and PGC-1β gene expression in twins. J. Clin. Invest. 114 (2004) 1518-1526
16. Lucia A., Gomez-Gallego F., Barroso I., Bandrés F., San Juan A.F., Chicharro J.L., Ekelund U., Brage S., Earnest C.P., Wareham N.J., and Franks P.W. PPARGC1A genotype (Gly482Ser) predicts exceptional endurance capacity in European men. J. Appl. Physiol. 99 (2005) 344-348
17. Lucia A., Gómez-Gallego F., Chicharro J.L., Celaya K., Córdova A., Villa G., Alonso J.M., Barriopedro M., Pérez M., and Earnest C.P. Is there an association between ACE and CKMM polymorphisms and cycling performance status during 3-week races?. Int. J. Sports Med. 26 (2005) 442-447
18. Lucia A., Gómez-Gallego F., Santiago C., Earnest C., Rabadán M., Alonso J.M., Hoyos J., Córdova A., Villa G., and Foster C. ACTN3 Genotype in professional endurance cyclists. Int. J. Sports Med. 27 (2006) 880-884
19. A. Lucia, F. Gómez-Gallego, C. Santiago, J.L. Maté-Muñoz, C. Chamorro-Viña, G. Nogales-Gadea, C. Foster, J.C. Rubio, A.L. Andreu, M.A. Martín, J. Arenas, The 577X allele of the ACTN3 gene is associated with improved exercise capacity in women with McArdle's disease, Neuromuscul. Disord., in press.
20. Martin M.A., Rubio J.C., Buchbinder J., del Hoyo P., Teijeira S., Gámez J., Navarro C., Fernández J.M., Cabello A., Campos Y., Cervera C., Culebras J.M., Andreu A.L., Fletterick R., and Arenas J. Molecular heterogeneity of myophosphorylase deficiency (McArdle's disease): a genotype-phenotype correlation study. Ann. Neurol. 50 (2001) 574-581
21. Martinuzzi A., Sartori E., Fanin M., Valente L., Angelini C., Siciliano G., Mongini T., Tonin P., Tomelleri G., Toscano A., Merlini L., Bindoff L.A., and Bertelli S. Phenotype modulators in myophosphorylase deficiency. Ann. Neurol. 53 (2003) 497-502
22. J.L. Maté-Muñoz, M. Moran, M. Pérez, C. Chamorro-Viña, F. Gómez-Gallego, C. Santiago, L. Chicharro, C. Foster, G. Nogales-Gadea, J.C. Rubio, A.L. Andreu, M.A. Martín, J. Arenas, A. Lucia, Favorable responses to acute and chronic exercise in McArdle's patients, Neuromuscul. Disord. 2007 Jun 7; [Epub ahead of print].
23. McArdle B. Myopathy due to a defect in muscle glycogen breakdown. Clin. Sci. 10 (1951) 13-33
24. Mills M., Yang N., Weinberger R., Beggs A.H., Easteal S., and North K. Differential expression of the actin-binding proteins, α-actinin-2 and -3, in different species: implications for the evolution of functional redundancy. Hum. Mol. Genet. 10 (2001) 1335-1346
25. Puigserver P., and Spiegelman B.M. Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator. Endocr. Rev. 24 (2003) 78-90
26. Rico-Sanz J., Rankinen T., Joanisse D.R., Skinner J.S., Wilmore J.H., Rao D.C., and Bouchard C. Associations between cardiorespiratory responses to exercise and the C34T AMPD1 gene polymorphism in the HERITAGE Family study. Physiol. Genomics 14 (2003) 161-166
27. Rieder M.J., Taylor S.L., Clark A.G., and Nickerson D.A. Sequence variation in the human angiotensin converting enzyme. Nat. Genet. 22 (1999) 59-62
28. Rubio J.C., Martin M.A., Bautista J., Segura D., and Arenas J. Association of genetically proven myophosphorylase and AMP deaminase: a second case of "double trouble". Neuromuscul. Disord. 7 (1997) 387-389
29. Rubio J.C., Martin M.A., Del Hoyo P., Campos Y., Segura D., Navarro C., Ricoy J.R., Cabello A., and Arenas J. Molecular analysis of Spanish patients with AMP deaminase deficiency. Muscle Nerve 23 (2000) 1175-1178
30. Rubio J.C., Martin M.A., Rabadan M., San Juan A.F., Alonso J.M., Chicharro J.L., Pérez M., Arenas J., and Lucia A. Frequency of the C34T mutation of the AMPD1 gene in World-class endurance athletes-does this mutation impair performance?. J. Appl. Physiol. 98 (2005) 2108-2112
31. Rubio J.C., Garcia-Consuegra I., Nogales-Gadea G., Cabello A., Lucia A., Andreu A.L., Arenas J., and Martin M.A. A proposed molecular diagnosis flowchart for myophopshorylase deficiency (McArdle disease) in blood samples from Spanish patients. Hum. Mutat. 28 (2007) 203-204
32. Semple R.K., Crowley V.C., Sewter C.P., Christodoulides C., Considine R.V., Vidal-Puig A., and O'Rahilly S. Expression of the thermogenic nuclear hormone receptor coactivator PGC-1alpha is reduced in the adipose tissue of morbidly obese subjects. Int. J. Obes. Relat. Metab. Disord. 28 (2004) 176-179
33. Squire J.M. Architecture and function in the muscle sarcomere. Curr. Opin. Struct. Biol. 7 (1997) 247-257
34. Terada S., and Tabata I. Effects of acute bouts of running and swimming exercise on PGC-1alpha protein expression in rat epitrochlearis and soleus muscle. Am. J. Physiol. Endocrinol. Metab. 286 (2004) E208-E216
35. Tsujino S., Shanske S., Carroll J.E., Sabina R.L., and DiMauro S. Double trouble: combined myophosphorylase and AMP deaminase deficiency in a child homozygous for nonsense mutations at both loci. Neuromuscul. Disord. 4 (1995) 263-266
36. Tsujino S., Shanske S., and DiMauro S. Molecular genetic heterogeneity of myophosphorylase deficiency (McArdle disease). N. Engl. J. Med. 329 (1993) 241-245
37. Tunstall R.J., Mehan K.A., Wadley G.D., Bonen A., Hargreaves M., and Cameron-Smith D. Exercise training increases lipid metabolism gene expression in human skeletal muscle. Am. J. Physiol. Endocrinol. Metab. 283 (2002) E66-E72
38. Vega R.B., Huss J.M., and Kelly D.P. The coactivator PGC-1 cooperates with peroxisome proliferator-activated receptor alpha in transcriptional control of nuclear genes encoding mitochondrial fatty acid oxidation enzymes. Mol. Cell. Biol. 20 (2000) 1868-1876
39. Wang Y.X., Zhang C.L., Yu R.T., Nelson M.C., Bayuga-Ocampo C.R., Ham J., Kang H., and Evans R.M. Regulation of muscle fiber type and running Endurance by PPARδ. PLoS Biol. 2 (2004) e294
40. Williams A.G., Rayson M.P., Jubb M., World M., Woods D.R., Hayward M., Martin J., Humphries S.E., and Montgomery H.E. The ACE gene and muscle performance. Nature 10 403 (2000) 614
41. Woods D.R., Humphries S.E., and Montgomery H.E. The ACE I/D polymorphism and human physical performance. Trends Endocrinol. Metab. 11 (2000) 416-420
42. Yang N., Macarthur D.G., Gulbin J.P., Beggs A.H., Easteal S., and North K. ACTN3 genotype is associated with human elite athletic performance. Am. J. Hum. Genet. 73 (2003) 627-631